National Health Investors (NYSE:NHI) Issues Quarterly Earnings Results

National Health Investors (NYSE:NHI) posted its earnings results on Tuesday. The real estate investment trust reported $0.65 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.42), Zacks reports. National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The business had revenue of $63.32 million for the quarter, compared to analyst estimates of $67.93 million. During the same quarter in the previous year, the firm posted $1.08 EPS. The business’s revenue was up 1.7% compared to the same quarter last year. National Health Investors updated its FY24 guidance to $4.43-$4.44 EPS and its FY 2024 guidance to 4.430-4.440 EPS.

National Health Investors Stock Performance

NHI stock traded up $2.88 on Thursday, reaching $79.64. 451,067 shares of the company were exchanged, compared to its average volume of 194,790. The stock’s fifty day moving average price is $80.38 and its 200 day moving average price is $73.16. The firm has a market capitalization of $3.46 billion, a PE ratio of 27.07, a PEG ratio of 5.05 and a beta of 1.05. The company has a debt-to-equity ratio of 0.91, a current ratio of 10.27 and a quick ratio of 10.27. National Health Investors has a 12 month low of $49.25 and a 12 month high of $86.13.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a $0.90 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.52%. National Health Investors’s dividend payout ratio (DPR) is presently 122.45%.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on NHI. Bank of America began coverage on shares of National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price target for the company. Wells Fargo & Company downgraded shares of National Health Investors from an “overweight” rating to an “equal weight” rating and increased their price objective for the company from $81.00 to $86.00 in a research report on Tuesday, October 1st. Truist Financial raised their target price on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a report on Friday, August 30th. Finally, StockNews.com downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $73.29.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.